Brief: Acumen Pharmaceuticals, Inc. Q3 Income From Operations USD -16.039 Million

Acumen Pharmaceuticals

13/11/2023 12:00

Nov 13 (Reuters) - Acumen Pharmaceuticals, Inc. Q3 operating expenses USD
16.039 million.
* Q3 basic EPS USD -0.24
* Q3 net income USD -12.957 million